#ASTRO2014 - Impact of prior docetaxel, extent of disease, and prior bisphosphonates on hematologic safety of radium-223 dichloride from ALSYMPCA - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by J. M. Michalski,¹ C. Parker,² O. Sartor,³ N. J. Vogelzang,⁴ I. Haugen,⁵ S. Nilsson⁶ at the 56th Annual Meeting of the American Society for Radiation Oncology - September 14 - 17, 2014 - San Francisco, CA USA

Click HERE to listen to one of the authors, Oliver Sartor, MD, discuss this study

¹Washington University School of Medicine, St Louis, MO, USA;
²The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK;
³Tulane Cancer Center, New Orleans, LA, USA;
⁴Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA;
⁵Algeta ASA (Bayer), Oslo, Norway;
⁶Karolinska University Hospital, Stockholm, Sweden